Our approach is chemical biology and the development of new strategies for disrupting and studying complex biological processes to investigate their therapeutic potential.
The main focus of the lab is to use organic chemistry, medicinal chemistry, and chemical biology to explore new strategies to interfere with and study processes related to cancer biology.
This includes the development of small heterocyclic molecules but also new modalities in drug development such as oligonucleotides. The bioactive derivatives are designed using structure-based techniques or identified through screening-based strategies together with Chemical Biology Consortium Sweden (CBCS).
Most projects are interdisciplinary and collaborations with other research groups are common.